No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New Zenith Drug ZEN-3365 Publication
Reply New Message
Back To Forum List View

Not exactly a "new" compound, since they have published on this ZEN-3365 compound years ago, but a new ZEN-3365 paper just came out.

The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia

https://pubmed.ncbi.nlm.nih.gov/34333666/

 

3 Recommendations
Re: New Zenith Drug ZEN-3365 Publication
3
Toinv
Aug 04, 2021 06:09PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply